Related references
Note: Only part of the references are listed.A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
Kenechukwu O. Chudy-Onwugaje et al.
INFLAMMATORY BOWEL DISEASES (2019)
Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes
Abbi R. Saniabadi et al.
JOURNAL OF CLINICAL APHERESIS (2019)
Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis
Maite Casado-Bedmar et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Adherent-invasive Escherichia coli in inflammatory bowel disease
Carolina Palmela et al.
GUT (2018)
A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn's Disease and Control Subjects
John-Peter Ganda Mall et al.
INFLAMMATORY BOWEL DISEASES (2018)
Probiotics and the Gut Immune System: Indirect Regulation
Giorgio La Fata et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2018)
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
Stephanie Da Silva et al.
INFLAMMATORY BOWEL DISEASES (2018)
P851 Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis
L Koeninger et al.
Journal of Crohns & Colitis (2018)
A cytokine network involving IL-36γ, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage
Vu L. Ngo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Infliximab restores colonic barrier to adherent-invasive E-coli in Crohn's disease via effects on epithelial lipid rafts
Olena Yakymenko et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions
Vishnu Mohanan et al.
SCIENCE (2018)
Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence
Maria Lia Scribano
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease
Shu-Ling Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages
Rui Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death
Ricard Garcia-Carbonell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis
Christina L. Hayes et al.
SCIENTIFIC REPORTS (2018)
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo et al.
FRONTIERS IN MICROBIOLOGY (2018)
Mast cells at the crossroads of microbiota and IBD
Marco De Zuani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation
Knud Erik Bach Knudsen et al.
NUTRIENTS (2018)
Fecal transplantation for treatment of inflammatory bowel disease
Aamer Imdad et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Review article: the gut microbiome in inflammatory bowel diseaseavenues for microbial management
J. McIlroy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis
P. Kump et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
CX(3)CR1(+) Cell-Mediated Salmonella Exclusion Protects the Intestinal Mucosa during the Initial Stage of Infection
Angela L. Man et al.
JOURNAL OF IMMUNOLOGY (2017)
Mechanisms of inflammation-driven bacterial dysbiosis in the gut
M. Y. Zeng et al.
MUCOSAL IMMUNOLOGY (2017)
Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications
Daniel Muthas et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice
Federica Ungaro et al.
GASTROENTEROLOGY (2017)
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection
Stephan J. Ott et al.
GASTROENTEROLOGY (2017)
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
Massimo C. Fantini et al.
INFLAMMATORY BOWEL DISEASES (2017)
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
Grainne Holleran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease
Guang Xi Zhou et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
Sudarshan Paramsothy et al.
LANCET (2017)
The Interplay between Defensins and Microbiota in Crohn's Disease
Lorena Coretti et al.
MEDIATORS OF INFLAMMATION (2017)
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease (vol 23, pg 579, 2017)
Nathaniel R. West et al.
NATURE MEDICINE (2017)
Gut microbiota and IBD: causation or correlation?
Josephine Ni et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Role of autophagy in the pathogenesis of inflammatory bowel disease
Tomoya Iida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study
Beatriz Lobo et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Jesmond Dalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases
Federica Ungaro et al.
FRONTIERS IN IMMUNOLOGY (2017)
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
Paul W. O'Toole et al.
NATURE MICROBIOLOGY (2017)
Dynamics of the human gut microbiome in inflammatory bowel disease
Jonas Halfvarson et al.
NATURE MICROBIOLOGY (2017)
Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli
Ali Shawki et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease
Kathryn L. Pothoven et al.
TISSUE BARRIERS (2017)
Review article: the human intestinal virome in health and disease
S. R. Carding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Can probiotics modulate human disease by impacting intestinal barrier function?
Peter A. Bron et al.
BRITISH JOURNAL OF NUTRITION (2017)
Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages
Ilana Gabanyi et al.
CELL (2016)
Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway
Hong-Qian Chu et al.
DIGESTIVE AND LIVER DISEASE (2016)
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
Christian L. Hvas et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Mast cell stabilisers
Tao Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Protease inhibition as new therapeutic strategy for GI diseases
Nathalie Vergnolle
GUT (2016)
Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation
Masakazu Shinohara et al.
Journal of Atherosclerosis and Thrombosis (2016)
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
R. K. Boyapati et al.
MUCOSAL IMMUNOLOGY (2016)
Tocilizumab and the risk of intestinal perforation
Lydia Shipman
Nature Reviews Rheumatology (2016)
Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases
Caroline Meyer Olesen et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Mucosa-attached bacterial community in Crohn's disease coheres with the clinical disease activity index
Holger Schaeffler et al.
ENVIRONMENTAL MICROBIOLOGY REPORTS (2016)
An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
Artemis P. Simopoulos
NUTRIENTS (2016)
Neutrophils: Their Role in Innate and Adaptive Immunity
Carlos Rosales et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel disease
Sara Al-Ghadban et al.
SCIENTIFIC REPORTS (2016)
Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis
Matthew Chak Hin Szeto et al.
CASE REPORTS IN IMMUNOLOGY (2016)
Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease
Shuhei Hosomi et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage
Gao Tan et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Noortje G. Rossen et al.
GASTROENTEROLOGY (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Andrea Michielan et al.
MEDIATORS OF INFLAMMATION (2015)
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
Benoit Chassaing et al.
NATURE (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Epidemiology and risk factors for IBD
Ashwin N. Ananthakrishnan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Omega-3 fatty acids and inflammation: A perspective on the challenges of evaluating efficacy in clinical research
Ann C. Skulas-Ray
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
The resolution of inflammation: Principles and challenges
Sarah E. Headland et al.
SEMINARS IN IMMUNOLOGY (2015)
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Charles N. Serhan et al.
SEMINARS IN IMMUNOLOGY (2015)
Roles and regulation of the mucus barrier in the gut
Steve Cornick et al.
TISSUE BARRIERS (2015)
First Multicenter Study of Modified Release Phosphatidylcholine LT-02 in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
Max Karner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Tissue-Specific Signals Control Reversible Program of Localization and Functional Polarization of Macrophages
Yasutaka Okabe et al.
CELL (2014)
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
Filipe De Vadder et al.
CELL (2014)
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid et al.
CELL (2014)
IBD Candidate Genes and Intestinal Barrier Regulation
Declan F. McCole
INFLAMMATORY BOWEL DISEASES (2014)
Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Wei Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity
Daniel S. Pearl et al.
JOURNAL OF CROHNS & COLITIS (2014)
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
Ruben J. Colman et al.
JOURNAL OF CROHNS & COLITIS (2014)
Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
Calum C. Bain et al.
NATURE IMMUNOLOGY (2014)
Role of interleukin-22 in inflammatory bowel disease
Lin-Jing Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Immunopathology of inflammatory bowel disease
Kori L. Wallace et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Christopher G. Mayne et al.
INFLAMMATORY BOWEL DISEASES (2013)
Anti-TNF, Infliximab, and Adalimumab Can Be Effective in Eosinophilic Bowel Disease
Dan Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats
A. V. Keita et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
P03-024 – Early onset IBD treated by tocilizumab
R Helbling et al.
Pediatric Rheumatology (2013)
Altered Colonic Mucosal Polyunsaturated Fatty Acid (PUFA) Derived Lipid Mediators in Ulcerative Colitis: New Insight into Relationship with Disease Activity and Pathophysiology
Mojgan Masoodi et al.
PLOS ONE (2013)
Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications
Jane M. M. Natividad et al.
PHARMACOLOGICAL RESEARCH (2013)
Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis
Anders H. Carlsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
Gary R. Lichtenstein
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The Life and Death of Epithelia During Inflammation: Lessons Learned from the Gut
Stefan Koch et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Intestinal mast cells in gut inflammation and motility disturbances
Benedicte Y. De Winter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Abnormal Activation of Autophagy-Induced Crinophagy in Paneth Cells From Patients With Crohn's Disease
Elodie Thachil et al.
GASTROENTEROLOGY (2012)
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux et al.
GASTROENTEROLOGY (2012)
Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells
Ehud Zigmond et al.
IMMUNITY (2012)
Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers
Megan E. Himmel et al.
IMMUNOLOGY (2012)
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Anne Christine W. Vos et al.
INFLAMMATORY BOWEL DISEASES (2012)
Healing of intestinal inflammation by IL-22
Atsushi Mizoguchi
INFLAMMATORY BOWEL DISEASES (2012)
Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins
Ean-jeong Seo et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Expression and functional analysis of intestinal organic cation/L-carnitine transporter (OCTN) in Crohn's Disease
Marc Girardin et al.
JOURNAL OF CROHNS & COLITIS (2012)
Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon
Aymeric Rivollier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Defective IL10 Signaling Defi ning a Subgroup of Patients With Inflammatory Bowel Disease
Bernadette Begue et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
Zhenhua Xu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Inflammation and wound healing: the role of the macrophage
Timothy J. Koh et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Anti-Tumor Necrosis Factor-alpha Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
Anne Christine W. Vos et al.
GASTROENTEROLOGY (2011)
Eosinophils Express Muscarinic Receptors and Corticotropin-Releasing Factor to Disrupt the Mucosal Barrier in Ulcerative Colitis
Conny Wallon et al.
GASTROENTEROLOGY (2011)
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
Patricia Lepage et al.
GASTROENTEROLOGY (2011)
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
Marie Joossens et al.
GUT (2011)
Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog
Maya Saleh et al.
IMMUNITY (2011)
Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria
Usriansyah Hadis et al.
IMMUNITY (2011)
Is Metabolic Stress a Common Denominator in Inflammatory Bowel Disease?
Ida Schoultz et al.
INFLAMMATORY BOWEL DISEASES (2011)
Invasive Potential of Gut Mucosa-derived Fusobacterium nucleatum Positively Correlates with IBD Status of the Host
Jaclyn Strauss et al.
INFLAMMATORY BOWEL DISEASES (2011)
Recent advances in IL-22 biology
Lauren A. Zenewicz et al.
INTERNATIONAL IMMUNOLOGY (2011)
Autophagy in immunity and inflammation
Beth Levine et al.
NATURE (2011)
Epithelial crosstalk at the microbiota-mucosal interface
Jerry M. Wells et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation To Resolve or Not?
Charles N. Serhan
AMERICAN JOURNAL OF PATHOLOGY (2010)
Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: A report based on 120 patients with active ulcerative colitis
Tomotaka Tanaka et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2010)
A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
Ben P. Willing et al.
GASTROENTEROLOGY (2010)
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
Tamira K. Klooker et al.
GUT (2010)
Thiopurine Therapy in Inflammatory Bowel Disease Patients: Analyses of Two 8-Year Intercept Cohorts
B. Jharap et al.
INFLAMMATORY BOWEL DISEASES (2010)
Monocyte Chemoattractant Protein-1 Contributes to Gut Homeostasis and Intestinal Inflammation by Composition of IL-10-Producing Regulatory Macrophage Subset
Yasuhiro Takada et al.
JOURNAL OF IMMUNOLOGY (2010)
Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells
å. v. Keita et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Transmembrane TNF-α: structure, function and interaction with anti-TNF agents
Takahiko Horiuchi et al.
RHEUMATOLOGY (2010)
Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease
Patrick Danoy et al.
PLOS GENETICS (2010)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
R. Corinaldesi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine
P-Y Zheng et al.
GUT (2009)
Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease
A. M. Muise et al.
GUT (2009)
High-frequency Haplotypes in the X Chromosome Locus TLR8 Are Associated with Both CD and UC in Females
Masayuki Saruta et al.
INFLAMMATORY BOWEL DISEASES (2009)
Comparative anatomy and phylogenetic distribution of the mammalian cecal appendix
H. F. Smith et al.
JOURNAL OF EVOLUTIONARY BIOLOGY (2009)
Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease
Akira Andoh et al.
JOURNAL OF IMMUNOLOGY (2009)
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-alpha(4)beta(7) Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
Dulce Soler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Probiotic E-coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
M. Moendel et al.
MUCOSAL IMMUNOLOGY (2009)
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
Mark S. Silverberg et al.
NATURE GENETICS (2009)
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
Jeffrey C. Barrett et al.
NATURE GENETICS (2009)
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser et al.
CELL (2008)
In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naive patients
T. Tanaka et al.
DIGESTIVE AND LIVER DISEASE (2008)
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Ken Sugimoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro
C. Wallon et al.
GUT (2008)
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
Sya N. Ukena et al.
PLOS ONE (2007)
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Masayuki Saruta et al.
CLINICAL IMMUNOLOGY (2007)
Induction of human β-defensin 2 by the probiotic Escherichia coli nissle 1917 is mediated throuah flagellin
Miriam Schlee et al.
INFECTION AND IMMUNITY (2007)
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier
Luying Peng et al.
PEDIATRIC RESEARCH (2007)
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
S. Zeissig et al.
GUT (2007)
The innate signaling of dangers and the dangers of innate signaling
Philippe J. Sansonetti
NATURE IMMUNOLOGY (2006)
Muc2-deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection
Maria Van der Sluis et al.
GASTROENTEROLOGY (2006)
An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis
M Takahashi et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior:: A case-control and meta-analysis study
CM Onnie et al.
INFLAMMATORY BOWEL DISEASES (2006)
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Eosinophil granulocytes are activated during the remission phase of ulcerative colitis
M Lampinen et al.
GUT (2005)
Eosinophils alter colonic epithelial barrier function: role for major basic protein
GT Furuta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease
J Maul et al.
GASTROENTEROLOGY (2005)
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity
LE Smythies et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Crohn's disease is associated with a toll-like receptor-9 polymorphism
HP Török et al.
GASTROENTEROLOGY (2004)
Genetic variation in DLG5 is associated with inflammatory bowel disease
M Stoll et al.
NATURE GENETICS (2004)
Functional variants of OCTN cation transporter genes are associated with Crohn disease
VD Peltekova et al.
NATURE GENETICS (2004)
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
SJ Ott et al.
GUT (2004)
Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
L Dubuquoy et al.
GASTROENTEROLOGY (2003)
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
P Seksik et al.
GUT (2003)
The importance of the ratio of omega-6/omega-3 essential fatty acids
AP Simopoulos
BIOMEDICINE & PHARMACOTHERAPY (2002)
Intestinal mast cell progenitors require CD49dβ7 (αAβ7 integrin) for tissue-specific homing
MF Gurish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat
J Santos et al.
GUT (2001)
Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease
K Kyo et al.
JOURNAL OF HUMAN GENETICS (2001)
Secretion and tissue content of eosinophil cationic protein in Crohn's disease
S Winterkamp et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Share Paper
